🔎 Trials Near Me

Nyumbani › Unenepu › Massachusetts

Majaribio ya kliniki ya Unenepu katika jimbo la Massachusetts

Masomo 44 ya Unenepu yanatafuta washiriki katika vituo vya jimbo la Massachusetts.

Miji katika jimbo la Massachusetts

Maandishi rasmi ya utafiti (Kiingereza)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • K2 Medical Research - Foxborough, Foxborough
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07783802

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Lucida Clinical Trials, New Bedford
InaajiriHatua 3
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Boston Children's Hospital, Boston
InaajiriHatua 3
Umri 6 hadi 17 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Lucida Clinical Trials, New Bedford
InaajiriHatua 3
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Lucida Clinical Trials, New Bedford
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • Brigham and Women's Hospital Diabetes Program, Boston
  • MedVadis Research Corporation, Waltham
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, North Dartmouth
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Brigham and Womens Hospital, Boston
  • Btc of New Bedford, New Bedford
InaajiriHatua 3
Umri 45 hadi 99 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • Care Access - Quincy, Quincy
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • Skylight Health Research - Burlington, Burlington
  • Care Access - Quincy, Quincy
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

  • Knownwell, Needham
  • Lucida Clinical Trials, New Bedford
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07589608

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • Boston Medical Center, Boston
  • Knownwell, Needham
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT07351045

The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression

  • Massachusetts General Hospital, Boston
InaajiriHatua 4
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT07699445

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Methuen
InaajiriHatua 3Wajitolea wenye afya wanakaribishwa
Umri 18 hadi 79 · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

  • Knownwell, Needham
  • Lucida Clinical Trials, New Bedford
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  • Kailera Clinical Site, Boston
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07284901

Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia

  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Inaajiri
Umri 18 na zaidi · Wanawake · Imesasishwa 31 Ago 2026 · NCT04839614

PPDTM CorEvitasTM Obesity (OBR) Drug Effectiveness and Safety Registry

  • CorEvitas, LLC, Waltham
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 27 Ago 2026 · NCT07598981

Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity

  • Exponent Boston, Boston
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 20 Ago 2026 · NCT07776678

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Methuen
  • ACCOMPLISH-1 Research Site, Needham
InaajiriHatua 3
Umri 18 hadi 79 · Jinsia zote · Imesasishwa 10 Ago 2026 · NCT07654361

The Osteoarthritis Prevention Study

  • Brigham and Women's Hospital, Boston
InaajiriWajitolea wenye afya wanakaribishwa
Umri 50 na zaidi · Wanawake · Imesasishwa 23 Jul 2026 · NCT05946044

Family-Based Weight Wellness Treatment Through Food is Medicine and Group Medical Visits in Pediatric and Adult Primary Care

  • Tufts Medical Center, Boston
  • Tufts University, Boston
Inaajiri
Umri 12 hadi 17 · Jinsia zote · Imesasishwa 21 Jul 2026 · NCT07717658

Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food

  • Cambridge Health Alliance, Sommerville
Inaajiri
Umri 18 hadi 60 · Jinsia zote · Imesasishwa 16 Jul 2026 · NCT06988462

Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions

  • Massachusetts General Hospital, Boston
Inaajiri
Umri 18 na zaidi · Wanawake · Imesasishwa 13 Jul 2026 · NCT06557005

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

  • MedVadis Research Watertown, Waltham
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Jul 2026 · NCT07481630

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

  • Brigham and Women's Hospital, Boston
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Jun 2026 · NCT06138821

Trans-nasal Endoscopy for Bariatric Patients

  • Brigham and Women's Hospital, Boston
Inaajiri
Umri 18 hadi 90 · Jinsia zote · Imesasishwa 25 Jun 2026 · NCT06200961

BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer Prevention

  • Massachusetts General Hospital Cancer Center, Boston
Inaajiri
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 23 Jun 2026 · NCT07162337

Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity

  • Massachusetts General Hospital, Boston
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 27 Mac 2026 · NCT05933499

Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease

  • Brigham and Women's Hospital, Boston
  • Brigham and Women's Faulkner Hospital, Boston
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Mac 2026 · NCT05728697

Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure

  • Brigham and Women's Hospital, Boston
InaajiriUtafiti wa uchunguzi
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 2 Mac 2026 · NCT05711758

Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors

  • Massachusetts General Hospital Cancer Center, Boston
InaajiriHatua 1
Umri 18 hadi 50 · Jinsia zote · Imesasishwa 27 Feb 2026 · NCT07095517

Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children

  • New Balance Foundation Obesity Prevention Center, Boston
InaajiriWajitolea wenye afya wanakaribishwa
Umri 9 hadi 12 · Jinsia zote · Imesasishwa 8 Jan 2026 · NCT05464186

Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment

  • Diabetes Research Center, Boston
Inaajiri
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 30 Des 2025 · NCT07226947

Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population

  • Massachusetts General Hospital, Boston
InaajiriUtafiti wa uchunguzi
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 24 Des 2025 · NCT05799222

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

  • Boston Children's Hospital (Part C only), Boston
  • Brigham and Women's Hospital (Part C and Part D), Boston
InaajiriHatua 1/2Wajitolea wenye afya wanakaribishwa
Umri 12 hadi 65 · Jinsia zote · Imesasishwa 22 Des 2025 · NCT06239116

Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment

  • Brigham and Women's Hospital, Boston
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 10 Des 2025 · NCT06069622

Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans

  • McLean Hospital, Belmont
  • Brigham and Women's Hospital, Boston
InaajiriWajitolea wenye afya wanakaribishwa
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 5 Des 2025 · NCT06105164

Building Connections

  • Disparities Research Unit, Massachusetts General Hospital, Boston
Inaajiri
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 18 Nov 2025 · NCT07091032

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.